Cellosaurus cell line NT-32 (CVCL

Cross-references
Cell line name	NT-32
Accession	CVCL_C4N8
Resource Identification Initiative	To cite this cell line use: NT-32 (RRID:CVCL_C4N8)
Comments	Doubling time: 5.35 days (PubMed=36269546). Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
Sequence variations	Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asn486_Pro490del (c.1457_1471del); ClinVar=VCV000666267; Zygosity=Unspecified (PubMed=36269546). Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=36269546).
Disease	Pancreatic large cell neuroendocrine carcinoma (NCIt: C95582)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Female
Age at sampling	70Y
Category	Cancer cell line
Publications	PubMed=36269546; DOI=10.1007/s13402-022-00727-z; PMCID=PMC9747820 Viol F., Sipos B., Fahl M., Clauditz T.S., Amin T., Kriegs M., Nieser M., Izbicki J.R., Huber S., Lohse A.W., Schrader J. Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy. Cell. Oncol. (Dordr.) 45:1401-1419(2022)
Encyclopedic resources	Wikidata; Q116050016
Entry history
Entry creation	15-Dec-2022
Last entry update	19-Dec-2024
Version number	4